#News : Editas Medicine to present pre-clinical data demonstrating progression of in vivo medicines pipeline at #ASGCT2024 . Read the press release for details: bit.ly/3UbVIXr #geneediting #invivo #biotechnology

Discuss Targeted Licensing & Acquisitions at Longwood Fund Spring Massachusetts Institute of Technology (MIT) with leaders from Editas Medicine Servier Pharmaceuticals Arbor Biotechnologies & Fish & Richardson

Thank you to Dr. Christine Lee, Acting Associate Commissioner for Minority Health and Director of the OMHHE in the Office of the Commissioner at the U.S. FDA, for joining us today for a presentation in recognition of #NationalMinorityHealthMonth . FDA Minority Health and Health Equity

It was great to see so many of our Editors across locations join together in support of the rare disease community on #RareDiseaseDay to help raise awareness of rare diseases and their impact. #rarediseases #geneediting #biotechnology #InsideEditas

Last week, our Editors showed their stripes in honor of #RareDiseaseDay . We show our stripes to raise awareness and generate change for the 300 million people worldwide living with a rare disease. #rarediseases #geneediting #biotechnology #InsideEditas

From entering college in China at just 15 to co-inventing a drug for Bayer U.S. 🇺🇸, Mei’s career journey has been far from average. Now CMO at Editas Medicine, he’s not done yet.
#leadership #biospace
hubs.li/Q02mHb780

On this #EmployeeAppreciationDay , we thank our employees (fondly referred to as “Editors”) for all they do. The passion they bring to work each day enables us to drive our work forward to deliver transformative medicines to people living with serious diseases. #InsideEditas

Editor Sara Davis shares her perspective on the importance of #RareDiseaseDay . #rarediseases #ShowYourStripes

Today is #RareDiseaseDay , and our Editors are showing their stripes to support those impacted by rare diseases and to raise awareness. Learn more about #RareDiseases and how you can get involved: rarediseases.org/rare-disease-d…. NORD #ShowYourStripes

Earlier today, we reported business highlights and financial results for the fourth quarter and full year 2023. Learn more: bit.ly/42XUKlE #geneediting #biotechnology

In recognition of #RareDiseaseDay on February 29, Editor Olubunmi Afonja shares her thoughts on the importance of this day. #RareDiseaseDay #rarediseases #geneediting #biotechnology

Tune in today at 8 a.m. ET for a conference call and webcast where we will discuss results for the fourth quarter and full year 2023 and provide a corporate update. bit.ly/3IgNW9e #geneediting #biotechnology

Today, we announced business updates and financial results for the fourth quarter and full year 2023. Read the full press release for details: bit.ly/42XUKlE #geneediting #biotechnology

Tune in tomorrow at 8 a.m. ET for a conference call and webcast where we will discuss results for the fourth quarter and full year 2023 and provide a corporate update. bit.ly/49JGGhY #geneediting #biotechnology

Last week, our Editors gathered to celebrate Lunar New Year and enjoy a lion dance performance. Thank you to the Wah Lum Kung Fu & Tai Chi Academy for the excellent performance, and for celebrating with Editas! #InsideEditas

February 29 is #RareDiseaseDay , and we will be joining the #raredisease community in raising awareness and generating change for the 300 million people worldwide impacted by #raredisease s and their loved ones. To learn more, visit rarediseases.org/rare-disease-d…. NORD

Editas Medicine will host a conference call and webcast on Wednesday, February 28, 2024, at 8:00 a.m. ET to discuss results for the fourth quarter and full year 2023 and to provide a corporate update. Read the press release for details: bit.ly/49JGGhY

#News : Editas Medicine announces Fourth Quarter and Full Year 2023 Results Conference Call and upcoming investor events. Read the press release for details: bit.ly/49JGGhY #geneediting #biotechnology

We were pleased to join the Massachusetts Sickle Cell Association, the American Red Cross, and the #sicklecelldisease community at last week’s Sickle Cell Briefing at the MA State House to raise awareness of #SCD and how to close the gaps in treatment and care. #sicklecelldisease #SCD #sicklecellwarriors

#News : Editas Medicine to participate in upcoming investor conferences. Read the press release for details: bit.ly/3SAzY81 #geneediting #biotechnology